rac-4-(4-chlorobenzoyl)-1-(2,5-dimethoxyphenyl)-3-methylpiperazin-2-one

ID: ALA4091399

PubChem CID: 46036431

Max Phase: Preclinical

Molecular Formula: C20H21ClN2O4

Molecular Weight: 388.85

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(OC)c(N2CCN(C(=O)c3ccc(Cl)cc3)C(C)C2=O)c1

Standard InChI:  InChI=1S/C20H21ClN2O4/c1-13-19(24)23(17-12-16(26-2)8-9-18(17)27-3)11-10-22(13)20(25)14-4-6-15(21)7-5-14/h4-9,12-13H,10-11H2,1-3H3

Standard InChI Key:  VBILMTNSWHFDNE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    3.4958  -11.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4958  -12.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2079  -12.9126    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9199  -12.5042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9199  -11.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2079  -11.2626    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7819  -12.9177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7801  -11.2688    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2079  -10.4376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2079  -13.7376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4934  -14.1501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9223  -14.1501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9181  -14.9761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6317  -15.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3472  -14.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3445  -14.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6303  -13.7381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9244  -10.0266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9247   -9.2023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2098   -8.7889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4929   -9.2059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4961  -10.0288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7829  -10.4434    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0672  -10.0331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6394   -8.7902    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3538   -9.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0622  -15.3875    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  2  7  1  0
  1  8  2  0
  6  9  1  0
  3 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  9 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  9  1  0
 22 23  1  0
 23 24  1  0
 19 25  1  0
 25 26  1  0
 15 27  1  0
M  END

Associated Targets(Human)

FADS1 Tchem Fatty acid desaturase 1 (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Fads1 Fatty acid desaturase 1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 388.85Molecular Weight (Monoisotopic): 388.1190AlogP: 3.23#Rotatable Bonds: 4
Polar Surface Area: 59.08Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.73CX LogD: 2.73
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.81Np Likeness Score: -1.12

References

1. Fujimoto J, Okamoto R, Noguchi N, Hara R, Masada S, Kawamoto T, Nagase H, Tamura YO, Imanishi M, Takagahara S, Kubo K, Tohyama K, Iida K, Andou T, Miyahisa I, Matsui J, Hayashi R, Maekawa T, Matsunaga N..  (2017)  Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) Inhibitors.,  60  (21): [PMID:29023121] [10.1021/acs.jmedchem.7b01210]

Source